JB

Joe Betts-lacroix

CEO at Retro Biosciences

San Francisco, California

Overview 

Joe Betts-LaCroix is the CEO of Retro Biosciences, where he leads all teams and is ultimately responsible for achieving the company's mission. With a background in entrepreneurship and biotechnology, Joe has held advisory roles in several biotech startups and has served as the Executive Director of the HEALTH EXTENSION FOUNDATION. Highlights of Joe's career include his role as the CTO of Vium and his experience as an Entrepreneur In Residence at Playground Global.

Work Experience 

  • "CEO" i.e. ultimately responsible for the achieving our mission

    2021 - Current

Retro Biosciences focus on cellular reprogramming, autophagy and plasma-inspired therapeutics.

Raised $180,000,000.00 from Sam Altman.

  • Board Observer

    2017

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Raised $293,900,000.00 from OrbiMed, OUP (Osage University Partners), RA Capital Management, Lilly Ventures, Andreessen Horowitz, Sands Capital Ventures, Cormorant Asset Management, Pivotal bioVenture Partners, Longitude Capital and Amgen Ventures.

  • Advisory Board Member

    2012

    Assist in product strategy, funding and organizational development.

  • Executive Director

    2012

    Health Extension is a not-for-profit community working to promote investment in the biomedical research to prevent age-related diseases. Its flagship monthly salon series is attended by Silicon Valley scientists, investors, entrepreneurs, designers, developers.

  • Advisor

    2020 - 2021

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Raised $865,376,000.00 from NVIDIA, Laurion Capital Management, Invus, Baillie Gifford, Kinnevik, Mubadala Capital Ventures and Platinum Asset Management.

  • Entrepreneur In Residence

    2020 - 2021

Playground is an early-stage deep tech venture capital firm backing technical and scientific founders

  • CTO

    2013 - 2020

    [acquired by Recursion Pharmaceutics] Vium is accelerating medical advancement by bringing 21st century technology into living systems research.

Vium is a biotechnology company that develops digital biomarkers to transform preclinical research and animal welfare.

Raised $53,940,004.00 from Lux Capital, Founders Fund, Future Shape, Dolby Family Ventures and DCVC.

  • Part-time Partner

    2017 - 2019

  • IP Advisor

    2009 - 2019

    Advising on Intellectual property matters for this company which manages a medium-sized portfolio of patents.

Zetta Research is an intellectual property company that involves and provides incentives to the authors of the patent.

  • Mentor & Lecturer

    2009 - 2017

    Lecture on intellectual property and idea research at Founder Institute sessions in Paris, Munich, Berlin, NYC, DC, San Diego, Seattle, San Francisco, Istanbul and Palo Alto, as well as mentor and support startup CEOs building meaningful companies.

Articles About Joe

Relevant Websites